BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29633446)

  • 1. A novel INS mutation in a family with maturity-onset diabetes of the young: Variable insulin secretion and putative mechanisms.
    Johnson SR; McGown I; Oppermann U; Conwell LS; Harris M; Duncan EL
    Pediatr Diabetes; 2018 Aug; 19(5):905-909. PubMed ID: 29633446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and molecular characterization of a novel INS mutation identified in patients with MODY phenotype.
    Piccini B; Artuso R; Lenzi L; Guasti M; Braccesi G; Barni F; Casalini E; Giglio S; Toni S
    Eur J Med Genet; 2016 Nov; 59(11):590-595. PubMed ID: 27659712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further evidence that mutations in INS can be a rare cause of Maturity-Onset Diabetes of the Young (MODY).
    Boesgaard TW; Pruhova S; Andersson EA; Cinek O; Obermannova B; Lauenborg J; Damm P; Bergholdt R; Pociot F; Pisinger C; Barbetti F; Lebl J; Pedersen O; Hansen T
    BMC Med Genet; 2010 Mar; 11():42. PubMed ID: 20226046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maturity onset diabetes of the young in India - a distinctive mutation pattern identified through targeted next-generation sequencing.
    Chapla A; Mruthyunjaya MD; Asha HS; Varghese D; Varshney M; Vasan SK; Venkatesan P; Nair V; Mathai S; Paul TV; Thomas N
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):533-42. PubMed ID: 25041077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes.
    Molven A; Ringdal M; Nordbø AM; Raeder H; Støy J; Lipkind GM; Steiner DF; Philipson LH; Bergmann I; Aarskog D; Undlien DE; Joner G; Søvik O; ; Bell GI; Njølstad PR
    Diabetes; 2008 Apr; 57(4):1131-5. PubMed ID: 18192540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frameshift mutations in the insulin gene leading to prolonged molecule of insulin in two families with Maturity-Onset Diabetes of the Young.
    Dusatkova L; Dusatkova P; Vosahlo J; Vesela K; Cinek O; Lebl J; Pruhova S
    Eur J Med Genet; 2015 Apr; 58(4):230-4. PubMed ID: 25721872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of mutations in monogenic diabetes genes identified from high-throughput DNA sequencing of 6888 individuals.
    Bansal V; Gassenhuber J; Phillips T; Oliveira G; Harbaugh R; Villarasa N; Topol EJ; Seufferlein T; Boehm BO
    BMC Med; 2017 Dec; 15(1):213. PubMed ID: 29207974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic testing for monogenic diabetes using targeted next-generation sequencing in patients with maturity-onset diabetes of the young.
    Szopa M; Ludwig-Gałęzowska A; Radkowski P; Skupień J; Zapała B; Płatek T; Klupa T; Kieć-Wilk B; Borowiec M; Młynarski W; Wołkow P; Małecki MT
    Pol Arch Med Wewn; 2015; 125(11):845-51. PubMed ID: 26552609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-exome sequencing for mutation detection in pediatric disorders of insulin secretion: Maturity onset diabetes of the young and congenital hyperinsulinism.
    Johnson SR; Leo PJ; McInerney-Leo AM; Anderson LK; Marshall M; McGown I; Newell F; Brown MA; Conwell LS; Harris M; Duncan EL
    Pediatr Diabetes; 2018 Jun; 19(4):656-662. PubMed ID: 29417725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monogenic Childhood Diabetes: Dissecting Clinical Heterogeneity by Next-Generation Sequencing in Maturity-Onset Diabetes of the Young.
    Demirci DK; Darendeliler F; Poyrazoglu S; Al ADK; Gul N; Tutuncu Y; Gulfidan G; Arga KY; Cacina C; Ozturk O; Aydogan HY; Satman I
    OMICS; 2021 Jul; 25(7):431-449. PubMed ID: 34171966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A family with the Arg103Pro mutation in the NEUROD1 gene detected by next-generation sequencing - Clinical characteristics of mutation carriers.
    Szopa M; Ludwig-Galezowska AH; Radkowski P; Skupien J; Machlowska J; Klupa T; Wolkow P; Borowiec M; Mlynarski W; Malecki MT
    Eur J Med Genet; 2016 Feb; 59(2):75-9. PubMed ID: 26773576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maturity onset diabetes of youth (MODY) in Turkish children: sequence analysis of 11 causative genes by next generation sequencing.
    Ağladıoğlu SY; Aycan Z; Çetinkaya S; Baş VN; Önder A; Peltek Kendirci HN; Doğan H; Ceylaner S
    J Pediatr Endocrinol Metab; 2016 Apr; 29(4):487-96. PubMed ID: 26669242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic basis of early-onset, maturity-onset diabetes of the young-like diabetes in Japan and features of patients without mutations in the major MODY genes: Dominance of maternal inheritance.
    Yorifuji T; Higuchi S; Kawakita R; Hosokawa Y; Aoyama T; Murakami A; Kawae Y; Hatake K; Nagasaka H; Tamagawa N
    Pediatr Diabetes; 2018 Nov; 19(7):1164-1172. PubMed ID: 29927023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood.
    Edghill EL; Flanagan SE; Patch AM; Boustred C; Parrish A; Shields B; Shepherd MH; Hussain K; Kapoor RR; Malecki M; MacDonald MJ; Støy J; Steiner DF; Philipson LH; Bell GI; ; Hattersley AT; Ellard S
    Diabetes; 2008 Apr; 57(4):1034-42. PubMed ID: 18162506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maturity Onset Diabetes of the Young (MODY) in Tunisia: Low frequencies of GCK and HNF1A mutations.
    Ben Khelifa S; Martinez R; Dandana A; Khochtali I; Ferchichi S; Castaño L
    Gene; 2018 Apr; 651():44-48. PubMed ID: 29408271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MODY in Ukraine: genes, clinical phenotypes and treatment.
    Globa E; Zelinska N; Elblova L; Dusatkova P; Cinek O; Lebl J; Colclough K; Ellard S; Pruhova S
    J Pediatr Endocrinol Metab; 2017 Oct; 30(10):1095-1103. PubMed ID: 28862987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of ten causal genes in Turkish patients with clinically suspected maturity-onset diabetes of the young (MODY) using a targeted next-generation sequencing panel.
    Doğan M; Eröz R; Bolu S; Yüce H; Gezdirici A; Arslanoğlu İ; Teralı K
    Mol Biol Rep; 2022 Aug; 49(8):7483-7495. PubMed ID: 35733065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted next generation sequencing in patients with maturity-onset diabetes of the young (MODY).
    Özdemir TR; Kırbıyık Ö; Dündar BN; Abacı A; Kaya ÖÖ; Çatlı G; Özyılmaz B; Acar S; Koç A; Güvenç MS; Kutbay YB; Erdoğan KM
    J Pediatr Endocrinol Metab; 2018 Dec; 31(12):1295-1304. PubMed ID: 30447144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Who should have genetic testing for maturity-onset diabetes of the young?
    Naylor R; Philipson LH
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):422-6. PubMed ID: 21521318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel genetic mutation in a Portuguese family with GCK-MODY.
    Almeida C; Silva SR; Garcia E; Leite AL; Teles A; Campos RA
    J Pediatr Endocrinol Metab; 2014 Jan; 27(1-2):129-33. PubMed ID: 23843579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.